Cover image not available

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease

Publication Data

Title A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease
Contributors Janine Dretzke, National Co-ordinating Centre for HTA, NHS R & D HTA Programme
Publisher Prepress Projects Ltd. on behalf of NETSCC, HTA
Publication date 2011
Publication location Perth
Language English

Descriptive Notes

DOI: 10.3310/HTA 15060.

Topics

Crohn's disease :: Treatment
Crohn's disease :: Treatment :: Cost effectiveness

Catalogue Data

OBNB ID GBB148096
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.34406

ISBD

P1053 xii, 124 p.
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease. Published by Prepress Projects Ltd. on behalf of NETSCC, HTA in 2011. Publication and catalogue information, links to buy online and reader comments.